![]() |
市场调查报告书
商品编码
1625265
到 2030 年血库设备市场预测:按产品、采集方法、应用、最终用户和地区进行的全球分析Blood Banking Equipment Market Forecasts to 2030 - Global Analysis by Product, Mode of Collection, Application, End User and By Geography |
根据 Stratistics MRC 的数据,2024 年全球血库设备市场规模为 163.221 亿美元,预计到 2030 年将达到 239.507 亿美元,预测期内复合年增长率为 6.6%。
血库设备包括用于血液采集、处理、储存和输血的专用设备和技术,以确保血液製品的安全性和完整性。这包括自动血液处理设备、血浆分离器、离心机、储存冰箱和冷冻库、采血袋、血型和交叉配血系统。设备还包括输血加温器、运输容器和监测工具,用于监测输血和储存期间的温度和状况。为了提供有效的输血和捐血服务,这些技术对于维持血液製品品质、避免污染并确保临床实践中捐赠者和接受者的兼容性至关重要。
根据世界卫生组织 (WHO) 的数据,2018 年全球共进行了 1.185 亿次捐血。
慢性病和手术盛行率上升
慢性病和手术盛行率的上升是血库设备需求的主要驱动力。随着癌症、糖尿病和心血管疾病等慢性疾病的增加,定期输血和相关治疗的需求也增加。同样,包括器官移植和创伤护理在内的手术的激增需要有效的血液储存和管理。这一趋势正在推动对先进血库设备的需求,以确保医疗程序所需的血液製品的稳定和安全供应。
初期投资成本高
血库设备产业的初始投资成本高昂可能会阻碍创新技术的采用,特别是在小型或资金紧张的医疗机构。这种成本障碍限制了现代设备的使用,并降低了营运的安全性和效率。它还可能阻碍现金流,推迟血库服务的成长,并阻碍对基本维护和升级的投资,所有这些都将阻碍整体市场的扩张。
技术进步
技术进步透过提高血液采集、储存和输血的效率、准确性和安全性来推动市场发展。自动血型、病原体检测和冷冻系统等创新可确保更高的血液品质并减少人为错误。此外,先进的监控系统和资料分析整合增强了库存管理和可追溯性。这些发展正在推动市场发展,因为它们不仅简化了业务,而且满足了日益增长的输血需求,有助于改善患者的治疗效果和改善医疗保健服务。
供不应求
血库设备市场的血液供不应求可能导致治疗延迟、死亡率增加以及手术和紧急情况下的併发症。医院可能面临关键血液製品的短缺,影响病患照护。这种短缺也给血库带来了负担,增加了营运成本和对紧急捐血的依赖,扰乱了医疗保健系统,并增加了对先进血液储存和管理设备的需求,从而限制了市场的扩张。
COVID-19 大流行对血库设备市场产生了重大影响,由于封锁和社交疏远措施,供应链中断并减少了捐血活动。然而,对恢復期血浆的需求不断增加,人们对医疗基础设施的认识不断提高,刺激了对先进血库技术的投资,对疫情期间和疫情后的市场动态产生了各种影响。
血库产业预计将成为预测期内最大的细分市场
由于慢性病的流行、外科手术数量的增加和紧急医疗需求的增加,导致对离心机、血液储存冰箱和自动血液分析仪等先进设备的依赖增加,血库行业将在预测期内继续增长。全球最大的此外,对血液处理安全性和准确性的日益关注正在推动创新并推动市场成长。血库在塑造该产业的发展轨迹方面发挥关键作用。
预计自动采血领域在预测期间内复合年增长率最高
由于自动化血液采集系统简化了血液采集过程、减少了人工错误并提高了血液成分分离的准确性,因此预计自动化血液采集领域在预测期内将出现最高的复合年增长率。自动化可以加快处理速度,有助于满足医疗保健和紧急情况下对血液不断增长的需求。此外,它还支援遵守严格的品质标准并降低营运成本。资料分析的整合进一步优化库存管理和可追溯性,推动已开发市场和新兴市场的采用并推动市场成长。
由于慢性病盛行率上升、老年人口增加以及输血需求增加等因素,预计北美在预测期内将占据最大的市场占有率。此外,自动血液成分分离系统和血库资讯系统等血库设备的技术进步正在进一步推动市场成长。此外,严格的血液安全和品质保证监管标准正在推动该地区采用先进的血库设备。
由于慢性病的流行和需要输血的老年人数量的增加,预计亚太地区在预测期内的复合年增长率最高。鼓励自愿捐血的政府计划和扩大医院基础设施都做出了重大贡献。此外,血液处理、检测和储存方面的技术发展正在提高操作安全性和效率,进一步推动产业向前发展。
According to Stratistics MRC, the Global Blood Banking Equipment Market is accounted for $16,322.1 million in 2024 and is expected to reach $23,950.7 million by 2030 growing at a CAGR of 6.6% during the forecast period. Blood banking equipment includes specialized instruments and technologies used in blood collection, processing, storage, and transfusion to assure the safety and integrity of blood products. This comprises automated blood processing equipment, plasma separators, centrifuges, storage refrigerators and freezers, blood collection bags, and blood typing and crossmatching systems. Blood warmers, transit containers, and monitoring tools to keep tabs on temperature and conditions during transfusion and storage are also included in the equipment. In order to provide effective blood transfusion and donation services, these technologies are essential for preserving the quality of blood products, avoiding contamination, and guaranteeing donor and recipient compatibility in clinical settings.
According to the World Health Organization, 118.5 million blood donations were collected globally in 2018.
Rising Prevalence of Chronic Diseases and Surgeries
The rising prevalence of chronic diseases and surgeries significantly drives the demand for blood banking equipment. As chronic conditions like cancer, diabetes, and cardiovascular diseases increase, the need for regular blood transfusions and related treatments grows. Similarly, the surge in surgeries, including organ transplants and trauma care, necessitates efficient blood storage and management. This trend propels the demand for advanced blood banking equipment to ensure a steady and safe supply of blood products for medical procedures.
High Initial Investment Costs
Adoption of innovative technologies may be impeded by high initial investment costs in the blood banking equipment industry, particularly for smaller or more financially strapped healthcare facilities. This cost barrier restricts access to contemporary equipment, which lowers operating safety and efficiency. It may also hinder cash flow, postpone the growth of blood bank services, and deter investment in essential maintenance or upgrades, all of which would hinder market expansion as a whole.
Technological Advancements
Technological advancements are driving the market by improving efficiency, accuracy, and safety in blood collection, storage, and transfusion. Innovations such as automated blood typing, pathogen detection, and refrigeration systems ensure higher blood quality and reduce human errors. Additionally, the integration of advanced monitoring systems and data analytics enhances inventory management and traceability. These developments not only streamline operations but also meet the growing demand for blood transfusions, contributing to better patient outcomes and healthcare services, thus it propels market expansion.
Blood Supply Shortages
Blood supply shortages in the Blood Banking Equipment market can lead to delayed medical treatments, increased mortality rates, and complications during surgeries or emergencies. Hospitals may face a shortage of critical blood products, affecting patient care. This shortage also strains blood banks, leading to higher operational costs and reliance on emergency donations, disrupting healthcare systems and increasing the need for advanced blood storage and management equipment, thus it limits the market expansion.
The COVID-19 pandemic significantly impacted the Blood Banking Equipment market, disrupting supply chains and reducing blood donation drives due to lockdowns and social distancing measures. However, increased demand for convalescent plasma and heightened awareness of healthcare infrastructure spurred investments in advanced blood banking technologies, creating a mixed effect on market dynamics during and post-pandemic.
The blood banks segment is expected to be the largest during the forecast period
The blood banks segment is expected to be the largest during the forecast period due to increasing prevalence of chronic diseases, rising surgical procedures, and emergency care needs amplify the reliance on advanced equipment such as centrifuges, blood storage refrigerators, and automated blood analyzers. Additionally, the growing focus on safety and precision in blood handling fosters innovation, boosting market growth. Blood banks play a pivotal role in shaping this industry's trajectory.
The automated blood collection segment is expected to have the highest CAGR during the forecast period
The automated blood collection segment is expected to have the highest CAGR during the forecast period as these systems streamline collection processes, reducing manual errors and improving the precision of blood component separation. Automation enables faster processing, meeting rising blood demand in healthcare and emergency settings. Additionally, it supports compliance with stringent quality standards and reduces operational costs. The integration of data analytics further optimizes inventory management and traceability, driving adoption in developed and emerging markets, thereby boosting market growth.
North America is projected to hold the largest market share during the forecast period because of factors like increasing prevalence of chronic diseases, rising geriatric population, and growing demand for blood transfusions. Additionally, technological advancements in blood banking equipment, such as automated blood component separation systems and blood bank information systems, are further propelling market growth. Furthermore, stringent regulatory standards for blood safety and quality assurance are driving the adoption of advanced blood banking equipment in the region.
Asia Pacific is projected to witness the highest CAGR over the forecast period because chronic illnesses are becoming more common and the number of elderly people needing transfusions is increasing. Government programs encouraging voluntary blood donation and the expansion of hospital infrastructure both make substantial contributions. Moreover, technological developments in blood processing, testing, and storage improve operating safety and efficiency, drives the industry even more.
Key players in the market
Some of the key players in Blood Banking Equipment market include Medtronic, BD Medical, Boston Scientific Corporation, Argon Medical Devices, Novo Nordisk, Terumo Corporation, NIPRO Medical, B. Braun, Cardinal Health, Hi-Tech Medicare Devices, Abbott Laboratories, Beckman Coulter, Inc., bioMerieux SA, Bio-Rad Laboratories, Inc., Cerus Corporation, CSL Behring LLC and Fresenius Kabi AG.
In October 2024, Abbott announced a new, first-of-its-kind clinical trial designed to improve outcomes in patients with worsening heart failure who could benefit from advanced therapy options.
In September 2024, Abbott and Seed Global Health announced the launch of a new partnership to train and support highly skilled health workers to help advance maternal and child health in Malawi.
In August 2024, Abbott announced the expansion of its Pure Bliss by Similac line of organic and European-made infant formulas that give parents a variety of products to meet specific formula preferences.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.